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Abstract
Objective: We aimed to study the occurrence and development of axonal
pathology and the influence of astrocytes in vanishing white matter. Methods:
Axons and myelin were analyzed using electron microscopy and immunohisto-
chemistry on Eif2b4 and Eif2b5 single- and double-mutant mice and patient
brain tissue. In addition, astrocyte-forebrain co-culture studies were performed.
Results: In the corpus callosum of Eif2b5-mutant mice, myelin sheath thickness,
axonal diameter, and G-ratio developed normally up to 4 months. At
7 months, however, axons had become thinner, while in control mice axonal
diameters had increased further. Myelin sheath thickness remained close to nor-
mal, resulting in an abnormally low G-ratio in Eif2b5-mutant mice. In more
severely affected Eif2b4-Eif2b5 double-mutants, similar abnormalities were
already present at 4 months, while in milder affected Eif2b4 mutants, few
abnormalities were observed at 7 months. Additionally, from 2 months onward
an increased percentage of thin, unmyelinated axons and increased axonal den-
sity were present in Eif2b5-mutant mice. Co-cultures showed that Eif2b5
mutant astrocytes induced increased axonal density, also in control forebrain
tissue, and that control astrocytes induced normal axonal density, also in
mutant forebrain tissue. In vanishing white matter patient brains, axons and
myelin sheaths were thinner than normal in moderately and severely affected
white matter. In mutant mice and patients, signs of axonal transport defects
and cytoskeletal abnormalities were minimal. Interpretation: In vanishing white
matter, axons are initially normal and atrophy later. Astrocytes are central in
this process. If therapy becomes available, axonal pathology may be prevented
with early intervention.
Introduction
Vanishing white matter (VWM) commonly presents in
early childhood, but onset may vary between antenatal
period to senescence.1 Age of onset is inversely related to
clinical severity.2 Clinically, VWM is characterized by
chronic neurological decline with additional episodes of
rapid, severe deterioration provoked by stressors like
febrile infections and minor head trauma, which may end
in coma and death.3–6 As yet, no curative treatment is
available.
VWM is caused by mutations in the genes encoding
the five subunits of the eukaryotic translation initiation
factor 2B (eIF2B), EIF2B1 through EIF2B5.7,8 eIF2B is an
enzyme complex essential for translation of mRNAs into
proteins and central in downregulating the rate of
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translation under different stress conditions.9 It is unclear
why mutations in this housekeeping factor lead to a dis-
order specifically affecting the brain white matter, whereas
other organs are mostly spared.10
The neuropathological findings in VWM include dif-
fuse lack of myelin and cystic degeneration of the cerebral
white matter.5,11 U-fibers, corpus callosum, internal cap-
sule, and brainstem are better preserved.5,6,12 Considering
the degree of cerebral white matter damage, reactive
astrogliosis is disproportionately meager.13,14 Astrocytes
are dysmorphic and immature.13–15 In relatively preserved
white matter areas, lack of myelin is associated with
increased numbers of oligodendrocyte progenitor cells
(OPCs), while mature, myelinating oligodendrocytes are
scarce.13,16,17
Axons are lost in cavitated white matter and their
numbers are variable in less severely involved
areas.5,6,12,13,18 Remaining axons have been reported as
abnormally thin.6 Axonal swellings and spheroids have
been described around cavitated areas and in the subcor-
tical white matter.19,20 Otherwise, axons have been
reported as microscopically intact with a normal
cytoskeleton at ultrastructural level.13,19,21 Cortex and
central gray matter structures remain largely preserved
without evident neuronal loss.5,6,13,14,18,20
White matter astrocytes and oligodendrocytes are selec-
tively affected.11,14,15,22 Recent studies indicate that astro-
cyte dysfunction is primary and oligodendrocyte
dysfunction secondary.16,23 As astrocytes and oligodendro-
cytes are important for axonal support, their dysfunction
in VWM may affect axonal integrity and function, but a
primary axonal defect in VWM has not been ruled out.24–26
In this study, we investigated axonal morphology in brain
tissue of VWM patients and mutant mice, in the latter at
different time points, and used primary cell cultures to
assess whether axonal abnormalities are primary or sec-
ondary to abnormality of VWM astrocytes.
Materials and Methods
Animals
Mouse models (background strain C57Bl/6J) were gener-
ated by inserting a point mutation in Eif2b4 (Eif2-
b4Arg484Trp/Arg484Trp) or Eif2b5 (Eif2b5Arg191His/
Arg191His) and bred into homozygous single mutants as
well as heterozygous-homozygous double-mutants, which
in increasing order of severity are referred to as, respec-
tively, 2b4ho, 2b5ho, and 2b4/2b5heho mice.23 These mice
replicate the human disease in clinical and pathological
features and in variation in severity. Timed mating was
performed with wild-type or mutant mice, with the day
of plugging denoted as embryonic day 0 (E0).
Cell culture
Astrocytes or forebrain mixed cells were isolated from
cerebral hemispheres of E18 mice and cultured following
previously described methods with minor modifica-
tions.27–31 Cultures were kept in a humidified incubator
at 37°C and 7.5% CO2 at all times. For astrocyte cultures,
cells were passaged two times, frozen and stored in liquid
nitrogen until further use. Before starting a co-culture,
astrocytes were first plated into a flask and cultured for
1 week in order to let them recover. Astrocyte-forebrain
co-cultures were performed in poly-L-lysine-coated 96-
well plates (Greiner). Fifteen thousand astrocytes were
plated per well and cultured until confluence (4 days),
after which 15.000 forebrain mixed cells, including neu-
rons, oligodendrocytes, microglia, and a few astrocytes
per well were plated on top of the astrocytes. Multiple
wells with astrocytes were maintained without forebrain
cells in order to determine astrocyte monolayer purity. As
previously described, for the first 11 days, the co-culture
medium contained insulin, followed by 17 days without
insulin but with triodothyronine (T3, Sigma-Aldrich).
Half of the medium was replaced with fresh medium 3
times a week. Experiments were performed at least four
independent times with at least three replicates per com-
bination of astrocyte-forebrain co-culture.
Immunocytochemistry
Cells were fixed with 4% paraformaldehyde (PFA,
Thermo Scientific) and 4% sucrose (Sigma-Aldrich) for
20 min at room temperature, washed two times with
PBS, and permeabilized and blocked with 0.5% Triton
X100 (Sigma-Aldrich) and 10% normal goat serum
(Gibco) in PBS for 1 h at room temperature. Subse-
quently, cells were stained overnight at 4°C with primary
antibodies in staining solution containing PBS, 0.1% Tri-
ton X100, and 10% normal goat serum. Then, cells were
washed three times with PBS, followed by a 2-h incuba-
tion of secondary antibodies in staining solution. Finally,
cells were washed two times with PBS and stored in PBS
at 4°C until further analysis.
Primary antibodies used were directed against neuronal
nuclei (NeuN, MAB377, 1:150, Millipore), microtubule-
associated protein 2 (MAP2, AB5543, 1:3000, Chemicon),
neurofilament 165 (NF165, 2H3, 1:250, Hybridoma
Bank), neurofilament 200 (NF200, N4142, 1:2000, Sigma-
Aldrich), phosphorylated neurofilament (SMI-31R,
1:1000, Covance), nonphosphorylated neurofilament
(SMI-32R, 1:1000, Covance), vesicular glutamate trans-
porter 1 (VGLUT1, AB5905, 1:5000, Millipore), postsy-
naptic density 95 (PSD95, MA1-046, 1:250, Thermo
Scientific), myelin basic protein (MBP, ab7349, 1:400,
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Abcam), oligodendrocyte nuclei (Olig2, AB9610, 1:1000,
Chemicon), microglia (CD11b, M1/70.15.11.5.2, 1:50,
Hybridoma Bank), chondroitin sulfate proteoglycan
(NG2, AB5320, 1:200, Millipore), and glial fibrillary acidic
protein (GFAP, ZO334, 1:1000, Dako). Secondary anti-
bodies conjugated to Alexa Fluor (Thermo Fisher Scien-
tific) 488, 568, 594 (all 1:1000) or 647 (1:800) were used
as appropriate. Nuclei were stained with Hoechst (0.2
lg/mL, Molecular Probes).
Imaging
Culture plates were scanned using the Opera LX high
content screening system (PerkinElmer). For each condi-
tion, three wells for astrocyte monolayers or five to six
wells for astrocyte-forebrain co-cultures were analyzed.
For cell counts, 14 images (20x objective) were captured
per well. For quantitative analysis of neurite densities and
MBP, 30 images (40x objective) were captured per well.
For quantitative analysis of synapses 50 images (40x
objective) were captured per well.
Quantitative analysis
Quantitative analysis was performed using Columbus 2.2
(PerkinElmer). Neurite (NF165, NF200, SMI31, or SMI32
for axons and MAP2 for dendrites) densities were given as
area occupied by neurites relative to total area of the image
(with or without correction for differences in number of
NeuN+ neurons). MBP was quantified as area occupied by
MBP immunoreactivity relative to total area of the image.
Synaptic density was calculated by counting synapses
(VGLUT1+ or PSD95+) located on top of a dendrite or
within a distance of 1.6 lm from a dendrite and dividing
the number by total dendrite length per image. Co-localiza-
tion of VGLUT1+ and PSD95+ was determined by search-
ing for PSD95+ spots located on top of VGLUT1+ spots or
within a distance of 0.65 lm from VGLUT1+ spots.
SMI31- or SMI32-positive neurites were quantified when
co-localized with NF200- or MAP2-positive neurites and
given as total length in lm per well or as total length ratio
relative to NF200 or MAP2. Percentage of microglia present
in the astrocyte monolayer was determined by counting
CD11b-positive cells relative to the number of nuclei
(oligodendrocytes or neurons were not detected).
Electron microscopy
Previously, we reported on electron microscopy (EM)
analysis of corpus callosum of 7-month-old wild-type,
2b4ho and 2b5ho mice and 4-month-old 2b4/2b5heho mice,
because the latter do not live up to 7 months.23 Here, we
additionally analyzed wild-type and 2b5ho mouse corpus
callosum at 2 and 4 months (two animals per group).
Mouse brains were drop-fixed in 2% glutaraldehyde and
4% PFA in 0.1 mol/L sodium cacodylate buffer (pH 7.4).
Human EM analysis included formalin-fixed corpus callo-
sum tissue of a female 10-year-old control subject that
died due to a brainstem tumor and a female 10-year-old
patient diagnosed with classical VWM. Corpus callosum
was dissected, postfixed in 1% osmium tetroxide and
1.5% potassium ferricyanide in 0.1 mol/L sodium cacody-
late buffer, dehydrated and embedded in epoxy resin.
Sagittally cut ultrathin sections were contrasted with ura-
nyl acetate and lead citrate and analyzed using a FEI Tec-
nai 12 electron microscope. A peer researcher renamed
the images in order to guarantee blinded quantifications
by the assessor. Axonal diameters and myelin sheaths
thicknesses were measured for at least 400 axons per
genotype using ImageJ and G-ratios, defined as axon
diameter/total axon + myelin diameter, were calculated.
As most axons are not completely circular, the shortest
diameter was measured. In addition, percentages of
unmyelinated axons and total number of axons were
quantified for at least 10 fields of view per genotype.
Histochemistry and immunohistochemistry
From our collection of VWM patient brain tissue, tissue
of 14 patients, involving seven different brain regions
(frontal, temporal, parietal, and occipital lobes; corpus
callosum; internal capsule; and cerebellum) was analyzed
by two different investigators. However, being archive
material, only qualitative microscopic analysis of previ-
ously stained sections was possible and no additional
stains for quantification could be performed. Formalin-
fixed, paraffinembedded tissue sections (6 lm thick)
were deparaffinized and stained with haematoxylin and
eosin or Bodian. For immunohistochemistry, heatin-
duced antigen retrieval was performed in 0.01 mol/L
citrate buffer (pH 6) in microwave at low setting, fol-
lowed by incubation with antibodies against NF
(MON3004; 1:50; Monosan), MBP (MAB387; 1:50; EMD
Millipore), proteolipid protein (MCA839G; 1:3,000; AbD
Serotec), phosphorylated neurofilament (SMI-31R,
1:1000, Covance), or non-phosphorylated neurofilament
(SMI-32R, 1:1000, Covance) and subsequently a horserad-
ish peroxidase secondary antibody. Immunopositivity was
detected with 3,30-Diaminobenzidine (DAB) as chro-
mogen. Images were acquired on a Leica DM6000B
microscope (Leica Microsystems).
Golgi staining procedure
Golgi stain was performed on fresh 4-month-old mouse
brains (two wild-type and two 2b5ho mice) using the FD
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Rapid GolgiStain Kit (FD Neurotechnologies, Inc.)
according to the manufacturer’s instructions. Tissue sec-
tions were cut at 150 lm, stained, and coverslipped with
DePeX (Serva), after which images were acquired on a
confocal microscope (Zeiss LSM510) with a 10x objective
(numerical aperture 0.3, 0.7x mechanical zoom) or a 40x
oil objective (numerical aperture 1.3, 1x or 2.5x mechani-
cal zoom), as z stacks with a 1-lm interval. Images were
analyzed with the freely available RECONSTRUCT soft-
ware (http://synapses.clm.utexas.edu).32 Spine densities
were determined along primary apical dendrites of layer
V pyramidal neurons, starting quantification at a distance
of 25 lm from the cell body.
Statistical analysis
Mouse EM data were tested for median differences using
Mann–Whitney U test or Kruskal–Wallis test followed by
post hoc Mann–Whitney U test, as assumptions for para-
metric tests were not met.
Independent co-culture experiments were performed
at least four times with at least three replicates per
co-culture condition. To analyze the data of all experi-
ments simultaneously, we ran a multi-level analysis with
experiment as clustering variable. Astrocyte genotype,
forebrain genotype, and their interaction term were
included as fixed effects. The interaction term between
astrocyte and forebrain mixed cells was removed from
the models in case this term was not significant. To
accommodate variation across experiments in a specific
outcome parameter, and variation in the effects of astro-
cyte genotype and forebrain genotype, random effects
for these parameters were included in the model as nui-
sance parameters. Data are presented in multiple plots
comparing two possible combinations of astrocyte-fore-
brain (wild-type vs. 2b5ho cells) co-cultures, with each
data point representing the mean of an individually per-
formed experiment. Spine data were analyzed using an
independent Student’s t test.
All data were analyzed using two-sided tests. As effect
size, Pearson’s correlation coefficient r was used, with val-
ues of .10, .30, and .50 denoting a small, medium or large
effect, respectively. A Bonferroni correction of the a was
applied (standard a = 0.05) when performing multiple
Figure 1. EM pictures of wild-type and 2b5ho mouse corpus callosum at 2, 4, and 7 months of age. Axonal diameters in 7-month-old 2b5ho are
smaller than in wild-type mice. Scale bar: 1 lm for all pictures.
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Figure 2. Disproportionally smaller axonal diameter and lower G-ratio in VWM mouse corpus callosum in more severely affected animals. (A)
Whereas axonal diameter and myelin sheath thickness were normal or close to normal in 2- and 4-month-old 2b5ho mice, axonal diameter was
smaller in 7-month-old 2b5ho than in wild-type mice (wild-type median 0.61 vs. 2b5ho median 0.33, Z = 11.05, ****P < 0.0001, r = 0.46), while
myelin sheath thickness remained close to normal. In the 2b4/2b5heho mice, myelin sheaths were thicker than normal (wild-type median 0.64 vs. 2b4/
2b5heho median 0.75, Z = 3.91, ****P < 0.0001, r = 0.14). In the 2b4ho mice, the axons were smaller compared to wild-type mice (wild-type
median 0.61 vs. 2b4ho median 0.49, Z = 2.89, #P = 0.0039, r = 0.11; which is a borderline significant trend with a Bonferroni-corrected P value of
0.0033 for all 15 comparisons performed in A and B). Slopes of correlations between myelin sheath thickness and axonal diameter were similar
between wild-type mice and 2b4ho and 2b5ho mutants, but slightly higher in the 4-month-old 2b4/2b5heho mice. (B) G-ratio’s were comparable in 2-
and 4-month-old wild-type and 2b5ho mice and in 7-month-old wild-type and 2b4ho mice. Aberrant G-ratios were detected for 4-month-old 2b4/
2b5heho mice (wild-type median 0.76 vs. 2b4/2b5heho median 0.72, Z = 5.78, ****P < 0.0001, r = 0.20) and 7-month-old 2b5ho mice (wild-type
median 0.78 vs. 2b5ho median 0.66, Z = -11.68, ***P < 0.001, r = 0.49). (C) Wild-type mice showed a clear shift to thicker myelinated axons from 2
to 4, to 7 months of age, whereas the 2b5ho mice showed a shift to thicker axons from 2 to 4 months but shifted back to smaller axons at 7 months,
comparable as the 2-month-old mice. (A, B) Mann-Whitney U test.
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comparisons. Normality tests and multi-level analyses
were performed using IBM SPSS Statistics 22. All other
statistical analysis and plots were carried out and pre-
pared using Prism 6.0 (GraphPad Software, Inc).
Study approval
Mouse brain tissue was obtained in strict compliance with
the animal welfare policies of the Dutch government and
approved by the IACUC of the VU University of Amster-
dam. Written informed consent was obtained according
to the Declaration of Helsinki and was provided by
patients or their parents for the collection and use of
patients’ samples. The Medical Ethics committee of the
VU University Medical Centre approved the procedures.
Results
Secondary axonal atrophy in VWM mice
EM analysis of the corpus callosum of mice of different
ages was performed to investigate the onset and develop-
ment of possible abnormalities in axon size and
axon-myelin proportion (Fig. 1). There was an impact of
Figure 3. Thinner myelin in vanishing white matter patients’ corpus callosum. EM on formalin-fixed tissue of (A, B) a control and (C, D) a
vanishing white matter subject showed that, although several tissue preparation artifacts were present, myelin sheaths were thinner in patients’
corpus callosum than in the control (arrows indicate axons of similar size but with different myelin sheath thicknesses). (A, C) Scale bar: 1 lm. (B,
D) Pictures zoomed in on an axon. Scale bar: 500 nm.
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disease severity on axon diameter and axon diameter-mye-
lin thickness ratio. In clinically presymptomatic 2b5ho mice
at 2 and 4 months, no clear differences were seen
compared to wild-type mice, although myelin sheaths
tended to be slightly thinner (Fig. 2A, B). By contrast, in
clinically symptomatic 2b5ho mice at 7 months, clear
Figure 4. More thin unmyelinated axons and higher axonal density in VWM mouse corpus callosum. (A) EM pictures showing thin and
unmyelinated axons in corpus callosum of 7-month-old 2b4ho and 2b5ho mice and 4-month-old 2b4/2b5heho mice compared to 7-month-old wild-
type mice. Scale bar: 1 lm for all pictures. Picture on the right is zoomed in picture of 2b4/2b5heho mouse. (B) Quantification (at least 10 fields of
view per genotype and age) showed higher percentages of unmyelinated axons in VWM mice than in wild-type mice at 2 months (wild-type
median 11 vs. 2b5ho median 35, Z = 2.88, **P < 0.01, r = 0.47 by Mann–Whitney U test), 4 months (H(2) = 22.81, ****P < 0.0001 by
Kruskal–Wallis test, where 2b5ho and 2b4/2b5heho mice differ from wild-type mice by Mann–Whitney U test, Z = 3.17, P < 0.01, r = 0.48 and
Z = 4.38, P < 0.0001, r = 0.74, respectively), and 7 months (H(2) = 9.65, **P < 0.01 by Kruskal–Wallis test, where 2b4ho and 2b5ho mice differ
significantly from wild-type mice by Mann–Whitney U test, Z = 2.80, P < 0.01, r = 0.52 and Z = 2.09, P value below Bonferroni-corrected P
of 0.025, r = 0.40, respectively). (C) Quantification of the total number of axons per field of view (at least 10 fields of view per genotype and
age) showed higher axonal densities in the VWM mice than in the wild-type mice at 4 months (H(2) = 12.93, **P < 0.01 by Kruskal–Wallis test,
where 2b5ho mice differ from wild-type mice by Mann–Whitney U test, Z = -3.66, P < 0.001, r = 0.55) and 7 months (H(2) = 29.85,
****P < 0.0001 by Kruskal–Wallis test, where 2b4ho and 2b5ho mice differ from wild-type mice by Mann–Whitney U test, Z = -4,32, P < 0.0001,
r = 0.80 and Z = 4.36, P < 0.0001, r = 0.81, respectively). Data represent mean  SEM.
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differences were seen. While myelin sheaths remained on
average slightly thinner than in wild-type mice, axons had
become disproportionately thin for the myelin sheath
thickness, resulting in a lower G-ratio than in wild-type
mice, especially for thinner axons (Figs. 1 and 2A, B).
Interestingly, a few myelin sheaths were much thicker than
normal. In the more severely affected 2b4/2b5heho mice,
abnormalities were already present at 4 months, which is
end-stage for these mutants. Myelin sheaths were thicker
and axons were slightly thinner than in 4-month-old wild-
type mice, resulting in a decreased G-ratio (Fig. 2A, B).
Strikingly, again a few myelin sheaths were seen that were
much thicker than normal. In the less severely affected
2b4ho mice, abnormalities were less obvious; myelin
sheaths were close to normal, but axons were relatively
small, although with a striking variation in diameter and
presence of several very thick axons. Like wild-type mice,
the G-ratio was similar for different axonal sizes. A few
myelin sheaths were thicker than normal, but less so than
in 4-month-old 2b4/2b5heho mice and 7-month-old 2b5ho
mice.
Regarding the diameter distribution of myelinated
axons at different ages, an increase in axonal size in both
2b5ho mutant and wild-type mice occurred between 2 and
4 months, with a further increase in 7-month-old
wild-type mice, while axonal diameter distribution in
7-month-old 2b5ho mice had reversed to that of 2-month-old
mice, indicating secondary axonal atrophy (Fig. 2C).
Regarding variation in myelin sheath thickness in wild-
type and 2b5ho mice at different ages, 2b5ho mice had
slightly higher frequencies of very thin sheaths at 2 and
4 months and a greater variation in thickness at
7 months (data not shown).
Thin myelin sheaths and axons in VWM
patients
EM analysis of human corpus callosum clearly showed
thinner myelin sheaths in the VWM patient than in the
control, but because of postmortem artifacts and long-
term storage in formalin before being processed for EM,
no reliable quantification and statistical analysis could be
performed (Fig. 3). Histochemical and immunohisto-
chemical analysis of patients brain tissue revealed that
axons were normal where tissue damage was mild (mild
tissue rarefaction), but were thin where tissue damage
was at least moderate (severe tissue rarefaction to cavita-
tion, data not shown).
High numbers of thin, unmyelinated axons
and increased axonal density in 2b5ho
mouse corpus callosum; increased axonal
density in primary co-cultures
EM analyses of 7-month-old wild-type, 2b4ho, 2b5ho and
4-month-old 2b4/2b5heho mice revealed presence of many
thin, unmyelinated axons in the mutants’ corpus callo-
sum, with the highest numbers in the double-mutants
(Fig. 4A). Additional EM analyses of younger animals
showed that higher percentages of thin unmyelinated
axons were already present from 2 months onward,
although less high than at 4 and 7 months (Fig. 4B).
These thin axons were associated with a higher axonal
density at 4 and 7 months (Fig. 4C).
In order to further explore the development of axonal
abnormalities, we prepared primary myelinating cell cul-
tures consisting of a layer of mouse forebrain mixed cells,
including neurons, oligodendrocytes, microglia, and a few
astrocytes, plated on a monolayer of mouse forebrain-
derived astrocytes, cultured together for 4 weeks. The
astrocyte monolayers contained ~6.5% or ~3.1% micro-
glia when derived from wild-type or 2b5ho mice, respec-
tively (data not shown). Co-culture data of all
experiments were analyzed simultaneously with multi-
level analysis. When cultured with wild-type mixed fore-
brain cells, a monolayer of 2b5ho astrocytes suppressed
total MBP amounts compared to a monolayer of wild-
type astrocytes, (Fig. 5A, t(5.03) = 2.73, P < 0.05,
r = 0.77) and in most cultures, the percentage of Olig2-
positive cells expressing MBP, although the latter was
Figure 5. Higher axonal density in VWM astrocyte-based co-culture. (A) MBP amounts (t(5.03) = -2.73, P < 0.05, r = 0.77) and in most cultures
(B) percentages of MBP-expressing Olig2+ cell numbers (although overall not significant, t(4.03) = 1.69, P = 0.17, r = 0.64) were lower when
wild-type forebrain mixed cells were cultured on 2b5ho astrocytes than if cultured on wild-type astrocytes, while having no effect on (C) the total
number of Olig2+ cells (P = 0.68). (D) Co-culture of wild-type forebrain cells on wild-type versus 2b5ho astrocytes stained for axons (NF200, red),
dendrites (MAP2, green), and neuronal cell bodies (NeuN, cyan). For the sake of clarity, the astrocytes themselves are not shown. Scale bar:
20 lm. A higher axonal density was obtained when wild-type forebrain cells (t(7.07) = 3.86, **P < 0.01, r = .82, (E) or 2b5ho forebrain cells (t
(5.07) = 2.52, P = .052, r = 0.75, not shown) were cultured on 2b5ho astrocytes than on wild-type astrocytes, which was partly related to
variance in neuronal cell numbers (F, G). (H) A similar effect on axonal density was detected in cultures consisting of two layers of 2b5ho cells in
comparison to wild-type cells (t(5.10) = 3.92, *P < 0.05, r = 0.89), associated with a higher neuronal cell number (t(49.08) = 3.28, **P < 0.01,
r = 0.42, (I, J). No effect on axonal density was detected when 2b5ho forebrain cells in comparison to wild-type forebrain cells were cultured on
either wild-type astrocytes (K-M) or 2b5ho astrocytes (not shown). (E-M) The different plots present data of the same five to seven individual
experiments. Each data point represents the mean of an individually performed experiment, for the specified co-culture combination. Statistics
were obtained by multi-level analysis on the raw data of all experiments combined. Astr = astrocyte monolayer; Fb cells = forebrain cells.
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overall not significant (Fig. 5B, t(4.03) = 1.69, P = 0.17,
r = 0.64), while having no effect on the total number of
Olig2+ cells (Fig. 5C, P = 0.68).
Regarding the effect of 2b5ho astrocytes compared to
wild-type astrocytes on axonal density, we found a signifi-
cant main fixed effect for astrocyte (t(6.88) = 3.48,
P < .01, r = 0.80), but no main fixed effect for forebrain
mixed cells (t(4.92) = 1.31, ns, r = 0.51), indicating that
the genotype of the astrocyte monolayer does affect axo-
nal density, but the genotype of the forebrain mixed cells
on top does not. Further analysis demonstrated that the
2b5ho astrocyte monolayers promoted a higher axonal
density than wild-type astrocyte monolayers in wild-type
forebrain cells (Fig. 5D, E; t(7.07) = 3.86, P < 0.01,
r = 0.82) without changing neuronal cell numbers
(Fig. 5F, G). The difference in the effect of 2b5ho astro-
cytes compared to wild-type astrocytes on axonal density
for 2b5ho forebrain cells was smaller (data not shown;
borderline significance, t(5.07) = 2.52, P = .052,
r = 0.75). Comparing cultures in which both the astrocyte
and forebrain layers were either 2b5ho mutant or wild-type
showed that the effect of mutant astrocytes compared to
wild-type astrocytes on axonal density was similar to the
effects observed in wild-type forebrain cells (Fig. 5H; t
(5.10) = 3.92, P = 0.01, r = 0.89, vs. Fig. 5E), indicating
lack of a significant additional effect of the mutant fore-
brain cells on axonal density. Neuronal cell numbers in
cultures with both layers consisting of 2b5ho cells were
higher than when both layers consisting of wild-type cells
(t(49.08) = 3.28, P < 0.01, r = 0.42, Fig. 5I, J), indicating
some effect of the mutant astrocytes combined with the
mutant forebrain cells on neuronal cell number. When
cultured on wild-type astrocytes, 2b5ho forebrain cells had
no effects on axonal density or neuronal cell number
compared to wild-type forebrain cells (Fig. 5K–M) and
neither did they have an effect when cultured on 2b5ho
astrocytes (data not shown).
Regarding effects on dendritic density, neuronal cell
body size and on the ratio between axonal and dendritic
density, no significant differences were detected with these
combinations of wild-type or 2b5ho astrocytes and fore-
brain cells (Fig. 6 and data not shown).
Evidence of mild axonal damage in VWM
patient white matter
In order to assess whether axonal swellings and spheroids
primarily occur in regions with severe tissue damage, we
microscopically examined brain tissue of VWM patients
for the presence of axonal swellings and spheroids using
immunohistochemistry. In most patients, only a few scat-
tered swellings and spheroids were detected (Fig. 7A).
Also in severely damaged tissue only a few spheroids were
found (Fig. 7B), the presence of which was not dependent
on brain region (Fig. 7C). Of note was the presence of
many spheroids in the occipital lobe of one of the oldest
VWM patients (37 years at demise, Fig. 7D), while tissue
structure and myelin content (not shown) were relatively
preserved. No obvious signs of impaired axonal cytoskele-
tal architecture (SMI31 vs. SMI32) were detected in
patient tissue and co-culture experiments (data not
shown).
Figure 6. No significant differences in dendritic density and neuronal cell body size between co-cultures consisting of 2b5ho versus wild-type
mouse-derived cells. No effect of 2b5ho in comparison to wild-type astrocytes on neuronal cell body size was detected when wild-type forebrain
cells (A-C) or 2b5ho forebrain cells (not shown) were cultured on top. Also two layers of 2b5ho versus wild-type cells (D-F) or 2b5ho forebrain cells
on either (C) wild-type astrocytes or 2b5ho astrocytes (not shown) did not give a difference in dendritic density or neuronal cell body size. (A-I)
The different plots present data of the same five to seven individual experiments, the same experiments as plotted in Fig. 4. Each data point
represents the mean of an individually performed experiment, for the specified co-culture combination. Statistics were obtained by multi-level
analysis on the raw data of all experiments combined. Astr = astrocyte monolayer; Fb cells = forebrain cells.
Figure 7. Axonal damage in VWM patients’ white matter. (A) NF-staining of frontal lobe of a 37-yr-old VWM patient showed a few swellings
(arrows). (B) Frontal lobe of a 10-yr-old VWM patient showed a few spheroids (arrows), whereas tissue damage was severe. (C) Internal capsule of the
same 10-yr-old VWM patient showed one spheroid (arrow), whereas tissue damage was meager. (D) NF staining of occipital lobe of the same 37-yr-
old VWM patient showed many axonal swellings and spheroids, while the tissue and myelin (not shown) was relatively intact. Scale bar: 50 lm for all.
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Unaffected synapse or spine density in
primary co-cultures or along primary apical
dendrites of layer V pyramidal neurons
Synaptic densities were quantified in co-cultures of vari-
ous combinations of wild-type and 2b5ho mouse-derived
cells (Fig. 8A–F). No difference in synaptic density was
found when wild-type forebrain mixed cells (P = 0.17,
Fig. 8D) or 2b5ho forebrain mixed cells (P = 0.40, not
shown) were cultured on a monolayer of 2b5ho astrocytes
compared to wild-type astrocytes. Also no significant
effect of 2b5ho versus wild-type forebrain cells on synaptic
density was found with either wild-type astrocytes
(P = 0.09, Fig. 8E) or 2b5ho astrocytes (P = 0.20, data not
shown). A trend for a lower synaptic density was found
when both layers consisted of 2b5ho cells compared to
two layers of wild-type cells (t(5.09) = 2.334, P = 0.07,
r = 0.72; Fig. 8F).
In Golgi stains of fresh 4-month-old mouse brains
(Fig. 8G–I), no difference in spine density was detected
along apical dendrites of wild-type versus 2b5ho layer V
pyramidal neurons (Fig. 8I).
Discussion
VWM is a devastating leukodystrophy, for which the
underlying cellular mechanisms have yet to be unraveled.
The current view is that astrocytes and oligodendrocytes
are selectively affected, and that astrocyte pathology drives
oligodendrocyte pathology.23 We previously developed
mutant VWM mice that are representative of the human
disease.23 Here, we studied axonal abnormalities in VWM
Eif2b4- and Eif2b5- mutant mice with different disease
severities and of different ages, in order to assess whether
and when axonal abnormalities occur. In addition, we used
primary astrocyte-forebrain co-cultures based on brain
cells of the Eif2b5 mice to assess whether axonal abnormal-
ities are primary or secondary to abnormality of VWM
astrocytes. We verified findings in brain tissue of patients.
In 2b5ho mice, average axonal diameter and relative
myelin sheath thickness and their variation are initially
normal, although myelin sheaths tend to be slightly thin-
ner from early on. It is only at 7 months that axons are
disproportionally small and myelin sheaths are still
slightly thinner than normal, but thicker than expected
for the axonal diameter, reflected by a lower G-ratio,
especially for the smaller axonal diameters. The distribu-
tion of axonal diameters in 2b5ho mice is close to normal
at 2 and 4 months with a normal shift to greater axonal
diameters at 4 months. However, the distribution of axo-
nal diameters at 7 months has returned to that at
2 months, while in wild-type mice, a further shift to lar-
ger diameters has occurred. In the more severely affected
2b4/2b5heho mice, deviating results for axonal diameter,
relative myelin sheath thickness, and G-ratio are already
present at 4 months. In the less severely affected 2b4ho
mice, differences from wild-type mice at the age of
7 months are less clear than in 2b5ho mice of the same
age. Overall, our results indicate that axons and relative
myelin sheath thickness are initially normal or close to
normal and only secondarily axonal atrophy occurs,
dependent on disease severity. Previously, a different
Eif2b5 mutant mouse model was reported to display a
higher proportion of thin axons in the internal capsule
associated with thinner myelin sheaths and a normal
G-ratio at 3 weeks.33 Axonal diameter and myelin sheath
thickness at later ages were not reported, but it was
demonstrated that in the cerebral peduncle of 15-month-
old mutants an increased proportion of axons had no or
thinner myelin than of wild-type mice.
The mouse findings were in part confirmed in VWM
patient tissue. Notably, patient tissue was obtained at
autopsy and therefore at end-stage disease, whereas mice
were sacrificed at the time of appearance of clinical symp-
toms. EM analysis of the corpus callosum of a VWM
patient suggested that myelin sheaths are thinner than in
an age-matched control subject, but, as explained above,
no definitive quantification of myelin sheath thickness or
axonal diameter could be performed. However, examina-
tion of multiple patients’ white matter regions overall
demonstrated that axons were normal where tissue dam-
age was mild, but were thin where tissue damage was
moderate to severe, in line with the findings in the VWM
mice. Thin axons in human brain tissue have been
described before.6 Taken together, these data indicate that
axonal morphological aberrancies are related to the sever-
ity of the white matter disease.
A new finding is the presence of numerous thin,
unmyelinated axons in the corpus callosum of mutant
mice, not present in similar numbers in wild-type mice,
resulting in increased axonal density. The highest percent-
age was found in the most severely affected 2b4/2b5heho
mice, suggesting that the density of thin unmyelinated
axons also correlates with disease severity. Our mouse
astrocyte-forebrain co-culture model provided us with the
opportunity to assess if axonal density is related to the
influence of mutant astrocytes on axons. Interestingly, in
2b5ho mouse-derived cell cultures axonal density is also
increased compared to wild-type cultures. A layer of
2b5ho astrocytes suffices to achieve this effect in wild-type
or 2b5ho forebrain cells; a layer of 2b5ho astrocytes cul-
tured with 2b5ho forebrain cells does not have an addi-
tional effect. Notably, a layer of 2b5ho forebrain cells on
wild-type astrocytes is associated with a normal axonal
density. These findings indicate that the effect is not
intrinsic to axons or neurons, but mediated by 2b5ho
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astrocytes, which promote higher axonal density. These
data imply that axons are not primarily affected in VWM,
but atrophy secondarily due to astrocytes or astrocyte-
secreted factors.
Another new finding is the observation of some very
large axons in the 7-month-old 2b4ho mice and some very
thick myelin sheaths in the 4-month-old 2b4/2b5heho mice
and 7-month-old 2b4ho and 2b5ho mice, associated with a
Figure 8. No difference in synapse or spine density in primary co-cultures or along primary apical dendrites of layer V pyramidal neurons (A) Co-
culture of wild-type forebrain cells on wild-type astrocytes stained for dendrites (MAP2, red), presynapses (VGLUT1, cyan), and postsynapses
(PSD95, green). For the sake of clarity, the astrocytes themselves are not shown. Scale bar: 20 lm. (B) Zoomed in picture of boxed area in A. (C)
Identification of dendrites and synapses included in quantification. No difference in synaptic density was detected when wild-type forebrain cells
(D) or 2b5ho forebrain cells (not shown) were cultured on 2b5ho astrocytes compared to wild-type astrocytes (P = 0.17 and P = 0.40,
respectively). Also no significant effect of 2b5ho versus wild-type forebrain cells was detected on either (E) wild-type or (not shown) 2b5ho
astrocytes (P = 0.09 and P = 0.20, respectively). (F) Two layers of 2b5ho cells in comparison to wild-type cells resulted in a trend for a lower
synaptic density ((t(5.09) = 2.334, P = 0.07, r = 0.72). (G, H) Golgi-stained mouse layer V pyramidal neuron. (G) Scale bar: 20 lm. (H) Scale
bar: 5 lm. (I) No difference in spine density was detected along primary apical dendrites of wild-type and 2b5ho layer V pyramidal neurons. (D-F)
The different plots present data of the same four to six individual experiments. Each data point represents the mean of an individually performed
experiment, for the specified co-culture combination. Statistics were obtained by multi-level analysis on the raw data of all experiments combined.
Astr = astrocyte monolayer; Fb cells = forebrain cells.
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very low G-ratio. Apparently the strict relationship between
axon diameter and myelin sheath thickness is disrupted in
more than one way. The cause of this remains unclear.
Previously, we showed that astrocyte pathology is a first
sign of the disease in VWM mice and occurs before mye-
lin pathology: we observed immaturity of astrocytes at
postnatal day 14, followed by lower than normal MBP
expression at day 21 in the same 2b5ho mouse model.23 In
co-cultures of different composition, we demonstrated
that oligodendrocyte maturation defect and lack of MBP
production are induced by VWM astrocytes and not
intrinsic to VWM oligodendrocytes.23 In thist study, we
confirmed that a layer of 2b5ho astrocytes in astrocyte-
forebrain co-cultures inhibits total MBP production and
the percentage of MBP-expressing Olig2+ cells.
All available evidence indicates that VWM astrocytes
are primarily affected and axonal pathology is also sec-
ondary. It is an open question whether the process of
axonal dystrophy is directly caused by the astrocytes
through, for example, lack of energy supply or secretion
of a toxic factor, or mediated through the impact of
astrocytes on oligodendrocytes and their ability to provide
metabolic support to axons.34,35 The effect of astrocytes
on axonal density may be related to immaturity of VWM
astrocytes, which better promote axonal growth or regen-
eration than mature astrocytes, while having no differen-
tial effect on dendrite growth.36–39 It has been postulated
that astrocytes provide general support for process growth
through secreted factors and that the differential effect of
mature versus immature astrocytes on axonal growth, but
not on dendritic growth, is due to cell-cell contact.40
Axonal swellings and spheroids, evidence of disturbed
axonal transport, are rare in VWM patient tissue. Most
patients have only a few scattered swellings or spheroids
throughout the brain white matter, even in the presence
of severe white matter damage. The current observation
of the highest number of spheroids in one of our oldest
patients, and the previous observation of spheroids in
older but not in younger 2b5ho mice suggests that axonal
transport problems develop over time.23 The mechanism
is unclear. We found no clear signs of impaired axonal
cytoskeletal architecture in patient tissue and co-culture
experiments. The older patient, who had a high number
of spheroids, also had relatively intact myelin, indicating
that spheroids are not caused by absence of myelin. Any-
how, disturbed axonal transport does not appear to be a
central problem in VWM.
It is likely that the clinical features in VWM are at least
in part caused by axonal dysfunction. In our 2b5ho mice,
clinical signs arise around the age of 5 months. Interest-
ingly, the shift from normal-sized axons to disproportion-
ally thin axons occurs between the ages of 4 and
7 months. These abnormalities potentially lead to a
reduction in signal conduction velocity, as observed in
VWM patients, which correlates more closely to axon
diameter than fiber (axon + myelin) diameter.41
To conclude, current data support the concept that
astrocytic dysfunction drives VWM pathology, affecting
not only oligodendrocyte mature functions but also the
trophic condition of axons. A very important finding is
that axons and relative myelin sheath thickness are ini-
tially normal or close to normal, indicating a window of
opportunity for treatment. It may be possible to prevent
axonal morphological changes when interventions are
undertaken in time.
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